Flanigan et al. (145) found that patients with renal cell carcinoma treated with IFN-α-2b after nephrectomy had longer survival than interferon alone, indicating that nephrectomy before IFN-α treatment for metastatic renal cell carcinoma can bring significant survival benefits to patients. This evidence concerns the gene IFNA2 and hereditary clear cell renal cell carcinoma.